Cyclodextrins are widely recognized for their ability to improve the solubility and stability of poorly soluble or chemically sensitive compounds. Owing to their unique cyclic molecular structure, cyclodextrins and their derivatives have become important functional excipients across pharmaceutical, chemical, and related formulation fields. In response to increasing technical and regulatory requirements, Xi’an Deli Biochemical has further refined the technical documentation and product support for its key cyclodextrin derivatives: hydroxypropyl betadex (HPBCD) and betadex sulfobutyl ether sodium (SBECD).
Cyclodextrins are cyclic oligosaccharides composed of glucose units linked by α-1,4 glycosidic bonds. Their molecular architecture features a hydrophilic outer surface and a relatively hydrophobic internal cavity, enabling the formation of inclusion complexes with a wide range of guest molecules. Chemical modification of the cyclodextrin structure can significantly enhance aqueous solubility and broaden application versatility.
Hydroxypropyl Betadex (HPBCD)
Hydroxypropyl betadex is a chemically modified β-cyclodextrin designed to overcome the limited solubility of native cyclodextrins. Its enhanced water solubility and favorable compatibility make HPBCD suitable for applications requiring effective solubilization, stabilization, and formulation flexibility across diverse systems.
Betadex Sulfobutyl Ether Sodium (SBECD)
Betadex sulfobutyl ether sodium is an anionic cyclodextrin derivative characterized by sulfobutyl ether substituents. This structure enhances electrostatic interactions with specific compounds, supporting improved solubility, complex stability, and formulation robustness in more demanding applications.
To better support formulation development, quality evaluation, and procurement processes, Xi’an Deli Biochemical has systematically updated product information for HPBCD and SBECD, including:
These improvements are intended to enhance transparency, reduce evaluation timelines, and support consistent product performance throughout the supply cycle.
Manufacturing Experience and Quality Assurance
Established in 1999, Xi’an Deli Biochemical brings 26 years of experience in the manufacturing of cyclodextrin derivatives. The company focuses on the controlled production of hydroxypropyl betadex and betadex sulfobutyl ether sodium, emphasizing process consistency, batch-to-batch reliability, and long-term supply stability. Structured quality management practices support customers’ technical, regulatory, and sourcing requirements.
Application Scope and Technical Collaboration
Based on cyclodextrin inclusion and stabilization mechanisms, HPBCD and SBECD are applicable across multiple technical fields, including pharmaceutical-related formulations, specialty chemicals, veterinary products, and other systems requiring enhanced solubility and stability. Xi’an Deli Biochemical continues to engage with partners through application-focused communication and technical collaboration to support evolving formulation needs.
About Xi’an Deli Biochemical Industry Companies
Founded in 1999, Xi’an Deli Biochemical Industry Companies is a specialized manufacturer of cyclodextrin derivatives, supplying hydroxypropyl betadex (HPBCD) and betadex sulfobutyl ether sodium (SBECD) to global customers. With a long-standing focus on product consistency, clear specifications, and practical technical support, the company remains committed to providing reliable cyclodextrin-based solutions.
If you want, I can also:
Just tell me where you plan to publish it.
